Although bone volume density over total volume (BV/TV, P >0.05) showed an increasing trend in the chidamide-treated group, the difference between the two groups was not significant.
← all excerpts
Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease.
1
—
—